A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This is a dose block-randomized, double-blind, placebo-controlled, single/multiple dosing, dose-escalation study. The study is designed to describe the relationship between multiple doses and pharmacokinetic parameters of DA-8031 as well as safety profile.
Epistemonikos ID: ea21ca71aa36e85d2fdf837c7cc7c1b9d4cc8726
First added on: May 05, 2024